PASADENA, Calif.--(BUSINESS WIRE)--
Jacobs
Engineering Group Inc. (NYSE:JEC) announced today it was awarded a
contract to provide engineering services and procurement for Alnylam
Pharmaceuticals’ (Nasdaq: ALNY) new manufacturing facility in Norton,
Massachusetts.
Under the terms of the agreement, Jacobs is providing engineering
services and procurement for the multi-product facility being built to
supply RNA interference-based therapeutics for clinical and commercial
needs.
In making the announcement, Jacobs Senior Vice President Global Life
Sciences Robert Norfleet stated, “Partnering with Alnylam on this major
development that enables the company to realize its goal of becoming a
fully integrated, commercial-stage company is an exciting opportunity.
We’re proud Alnylam turned to Jacobs as its design partner, and we look
forward to delivering a state- of- the-art facility.”
The 200,000 square foot facility is expected to be completed in 2018.
Jacobs is one of the world’s largest and most diverse providers of
full-spectrum technical, professional and construction services for
industrial, commercial and government organizations globally. The
company employs 60,000 people and operates in more than 30 countries
around the world. Its Global Life Sciences business is the largest
professional services provider to the pharmaceutical and biotechnology
industries. For more information, visit www.jacobs.com.
Statements made in this release that are not based on historical fact
are forward-looking statements. We base these forward-looking statements
on management’s current estimates and expectations as well as currently
available competitive, financial and economic data. Forward-looking
statements, however, are inherently uncertain. There are a variety of
factors that could cause business results to differ materially from our
forward-looking statements. For a description of some of the factors
which may occur that could cause actual results to differ from our
forward-looking statements please refer to our 2015 Form 10-K, and in
particular the discussions contained under Items 1 - Business, 1A - Risk
Factors, 3 - Legal Proceedings, and 7 - Management's Discussion and
Analysis of Financial Condition and Results of Operations. We do not
undertake to update any forward-looking statements made herein.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160804005004/en/
Source: Jacobs Engineering Group Inc.